Latest News

Tuesday, July 17, 2018

Save the Date: Skin Cancer Foundation's Champions for Change Gala this October

The Skin Cancer Foundation’s signature fundraising event, the Champions for Change Gala, is coming October 25 in New York City. Robert J. Friedman, MD will be honored as the 2019 Champ…

Read the full story

Monday, July 16, 2018

Cutera's New truSculpt iD Offers Personalized Body Sculpting

Cutera, Inc's new truSculpt® iD offers an evolution in body sculpting with unique hands-free capability and the ability to treat a full abdomen in as little as 15 minutes. truSculpt iD offers …

Read the full story

Monday, July 16, 2018

New From Candela: Vbeam Prima

Recently FDA-cleared, the Vbeam Prima from Candela offers two wavelengths to effectively treat a broad range of skin conditions including rosacea, spider veins, wrinkles, acne and …

Read the full story

Friday, July 13, 2018

Dermatologists, Skin Cancer Survivors Tell "Skin Cancers, Take a Hike!"

To help raise awareness of skin cancer prevention and detection, 12 dermatologists, skin cancer survivors, and their family and friends will tell “Skin Cancer, Take a Hike!” during a four-…

Read the full story

Thursday, July 12, 2018

Sensus Healthcare Forms Strategic Agreement with SkinCure Oncology

Sensus Healthcare, Inc., which specializes in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy (IGSRT), formed a strategic agr…

Read the full story

Thursday, July 12, 2018

New From InMode: Triton Multi-Wavelength Hair Removal Laser

InMode Ltd. is launching the Triton hair removal device. Recently cleared by the FDA, Triton is the first and only high power laser to offer simultaneous multi-wavelength hair removal firing, all…

Read the full story

Wednesday, July 11, 2018

Fourth Generation Retinoid Shows Promise in Acne Trials

New research reveals that trifarotene, a fourth-generation retinoid with potent and selective activity against only one particular retinoic acid receptor, may have an improved efficacy and safety prof…

Read the full story

Wednesday, July 11, 2018

Dermtech’s Noninvasive Melanoma Screen Improves Care, Lowers Cost

New research shows that DermTech’s Pigmented Lesion Assay (PLA) reduces cost while improving the care of patients with primary pigmented skin lesions suggestive of melanoma. The research appears…

Read the full story

Wednesday, July 11, 2018

About 415 Million People May Have Rosacea Worldwide

As many as 415 million people worldwide may have rosacea, according to new research in the British Journal of Dermatology. Dr. Jacob Thyssen and colleagues at the University of Copenhagen, Denmark,…

Read the full story

Wednesday, July 11, 2018

Nanotechnology May Improve Onychomycosis, Cut Costs

Nanotechnology can improve efinaconazole treatment for onychomycosis and make it more cost effective, according to new research in the Journal of Drugs in Dermatology. Adam Friedman, MD, professor …

Read the full story

Wednesday, July 11, 2018

Life Sciences Industry Eyes $1.5 Trillion Milestone

The life sciences industry is nearing a $1.5 trillion milestone, according to an analysis from Frost & Sullivan. The firm’s Global Life Sciences Industry Outlook, 2018 report finds that…

Read the full story

Tuesday, July 10, 2018

Rare Pediatric Skin Conditions Often Get Expensive, Inconsistent Care

Children with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have high rates of complications -- resulting in long and costly hospital stays -- and that treatment strategies v…

Read the full story

Friday, July 06, 2018

Jury Still Out on Environmental Effects of Chemical Sunscreens

In the wake of Hawaiian legislation banning the sale and distribution of sunscreens containing oxybenzone and octinoxate because they may contribute to coral bleaching, new research reviews the availa…

Read the full story

Monday, July 02, 2018

XELJANZ Receives EU Marketing Authorization for Adults with Active PsA

The European Commission (EC) has approved XELJANZ® (tofacitinib citrate) 5 mg twice daily (BID) in combination with methotrexate (MTX) for the treatment of active psoriatic arthritis (PsA) in adul…

Read the full story

Monday, July 02, 2018

PAH after Cryolipolysis May Not Be So 'Rare'

Paradoxical adipose hyperplasia (PAH) after cryolipolysis may be more common than previously thought according to a paper in the July issue of Plastic and Reconstructive Surgery®. While PA…

Read the full story
Load More